Section 32 is a venture capital firm in California that focuses on investing in the healthcare and information technology sectors. Founded 2017 in San Diego, California, United States by Bill Maris, it invests in series A, series B, seed, series C, and secondary markets. It portfolio companies include Cradle Genomics, Vineti, Legacy, XOKind, and Aspen Neuroscience. As of February 2020, Section 32 has made 33 investments. Their most recent investment was on February 9, 2020, when Vineti raised $35M. Section 32 has had three exits, the most notable of which include Auris Health, Alector, and Fulcrum Therapeutics. The company has raised two funds, their latest being Section 32 Fund 2. This fund was announced on February 21, 2019 and raised a total of $199.4M.